Bannert Manlik Consultants GmbH Germany

Specialized Pharma M&A Boutique operating since 1991 globally

Ms Ulrike Däxl
Ms Ulrike Däxl
Project Manager 
Mr Mathias Käsebier
Mr Mathias Käsebier
Senior Director 

Bayer AG Germany

Dr Ulrich Koch
VP BD&L Negotiations 

BIOPROJET PHARMA France

Mr JEAN GUILLAUME LECOMTE
CEO 

BMG PHARMA SPA Italy

Mr Marco Mochi
Director Business Development 

BMG PHARMA SPA Italy

BMG Pharma is involved in the development of new healthcare products in the areas of oral care, dermatology including aesthetics, anaemia, osteoarthritis & cancer supportive care.

The company has created a strong portfolio of intellectual property which it has developed into a number of products that have been partnered with companies around the world.

The company recently merged with Sigea,an Italian company with expertise in targeted functional ingredients development currently focused on modified sodium hyaluronate for application in a number of therapeutic areas including dermatology and oral care. This merger will allow BMG to accelerate the development of a number of new products to complement its portfolio.

Mr Paul Phull
Mr Paul Phull
COO 

Boehringer Ingelheim Corporate Center GmbH Germany

Mr Juergen Beck
Head of Strategic Transactions & Alliance Management 

Brueckner-IP Germany

IP Law Firm

Dr Christopher Brueckner
Patent Attorney